XTAMPZA ER 9 mg/1 (Oxycodone CAPSULE, EXTENDED RELEASE) 9 mg/1

XTAMPZA ER 9 mg/1 is an extended-release oxycodone capsule designed for oral use. It is commonly used for managing moderate to severe pain. This medication is formulated to provide long-lasting relief.

Strength

9 mg/1

Pack Size

20 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (24510-110-20)

Manufacturer / TM Owner

Collegium Pharmaceutical, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XTAMPZA ER 9 mg/1 is primarily used for the management of moderate to severe pain that requires around-the-clock, long-term treatment. The extended-release formulation is designed to provide consistent pain relief over an extended period. Patients often ask, 'What is XTAMPZA ER used for?' It is typically prescribed for conditions that necessitate continuous pain management.

Side Effects

Common effects of XTAMPZA ER 9 mg/1 may include drowsiness, constipation, and nausea. Some users may experience dizziness or vomiting. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

Precautions & Warnings

XTAMPZA ER 9 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. The capsules should not be crushed, chewed, or broken, as this can affect the extended-release mechanism. Always store the medication in a secure place to prevent misuse.

Avoid Interactions

XTAMPZA ER 9 mg/1 may interact with other medications, including alcohol, antidepressants, and certain pain relievers. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

XTAMPZA ER is used for managing moderate to severe pain that requires long-term, around-the-clock treatment.

XTAMPZA ER should be taken orally, whole, with water. Do not crush, chew, or break the capsules.

Common side effects may include drowsiness, constipation, nausea, dizziness, and vomiting.

It is generally advised to avoid alcohol while taking XTAMPZA ER, as it may increase the risk of side effects.

Store XTAMPZA ER in a secure place at room temperature, away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.